- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07715500
Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications
July 16, 2026 updated by: Institute of Liver and Biliary Sciences, India
Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications - Open Label Randomised Controlled Trial
Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases.
Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients.
Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is considered as the "Achilles heel" of liver transplantation and adequate imaging assessment of biliary anatomy can largely benefit the biliary anastomosis.
Preoperative imaging assessment of biliary anatomy is good for the selection of donors but may not indispensable for surgical planning and Intraoperative confirmative assessment of biliary anatomy with IOC was essential
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases.
Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients.
Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is considered as the "Achilles heel" of liver transplantation and adequate imaging assessment of biliary anatomy can largely benefit the biliary anastomosis.
Preoperative imaging assessment of biliary anatomy is good for the selection of donors but may not indispensable for surgical planning and Intraoperative confirmative assessment of biliary anatomy with IOC was essential
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dr Atul Renjit, MBBS, MS, DNB
- Phone Number: +91 9632060230
- Email: atulrenjit@gmail.com
Study Contact Backup
- Name: Dr Nilesh Sadashiv Patil, MCH
Study Locations
-
-
-
New Delhi, India, 110070
- Recruiting
- ILBS
-
Contact:
- Dr Atul Renjit, MBBS, MS, DNB
- Phone Number: +91 9632060230
- Email: atulrenjit@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- All prospective voluntary healthy liver donor of age 18-55
Exclusion Criteria:
- Type C/D Portal vein anatomy
- Left sided Gallbladder
- Right Posterior Graft
- Recipients undergoing Hepaticojejunostomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No MRCP GROUP
Magnetic Resonance Cholangiopancreatography is not done as part of Routine Liver donor workup
|
|
|
Experimental: MRCP GROUP
Magnetic Resonance Cholangiopancreatography is done as part of Routine Liver donor workup
|
Magnetic Resonance Cholangiopancreatography is being excluded from list of Investigation as part of Non inferiority trial
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To identify factors causing early biliary complications like type and number of arterial & biliary reconstruction, type of graft, number & size of Bile ducts in donor in both groups
Time Frame: 6 month of postop
|
6 month of postop
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Donor biliary complications in both group
Time Frame: 1 month of postoperative period
|
Bile leak or strictures in Liver Donors
|
1 month of postoperative period
|
|
Identify Risk factors for early Biliary complications in recipients
Time Frame: till 6 months of Post operative period of Liver transplant
|
Identify Risk factors for early Biliary complications in recipients
|
till 6 months of Post operative period of Liver transplant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2025
Primary Completion (Estimated)
July 15, 2026
Study Completion (Estimated)
August 30, 2026
Study Registration Dates
First Submitted
January 1, 2026
First Submitted That Met QC Criteria
July 16, 2026
First Posted (Actual)
July 20, 2026
Study Record Updates
Last Update Posted (Actual)
July 20, 2026
Last Update Submitted That Met QC Criteria
July 16, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IEC/2025/119/MA04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplant; Complications
-
PilloxaTerminatedLiver Transplant; Complications | Kidney Transplant; ComplicationsSweden
-
University of Rome Tor VergataRecruitingLiver Transplant; Complications | Kidney Transplant; ComplicationsItaly
-
Fundacion Clinic per a la Recerca BiomédicaRecruitingLiver Transplant; ComplicationsSpain
-
Société Française d'Anesthésie et de RéanimationLaboratoire français de Fractionnement et de BiotechnologiesRecruitingLiver Transplant; ComplicationsFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingLiver Transplant; ComplicationsItaly
-
Third Affiliated Hospital, Sun Yat-Sen Universitythe China Liver Transplant RegistryCompletedLiver Transplant; ComplicationsChina
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedLiver Transplant; ComplicationsSpain
-
Seoul St. Mary's HospitalEnrolling by invitationLiver Transplant; ComplicationsKorea, Republic of
-
Boston Scientific CorporationCompletedLiver Transplant; ComplicationsSpain, United States, Netherlands, Brazil
-
Seoul National University HospitalCompletedLiver Transplant; ComplicationsKorea, Republic of
Clinical Trials on Magnetic Resonance Cholangiopancreatography
-
Assistance Publique - Hôpitaux de ParisCompletedMagnetic Resonance Imaging | Caroli Disease | CholangiopancreatographyFrance
-
The General Authority for Teaching Hospitals and...RecruitingNon-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary ObstructionDiagnosis | Non-invasive Diffusion-weighted Imaging | Magnetic Resonance Cholangiopancreatography | Neoplastic Biliary ObstructionEgypt
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingPancreatic Cancer | Pancreas CancerUnited States
-
Sohag UniversityNot yet recruiting
-
PerspectumOxford University Hospitals NHS TrustCompletedCholecystitis; Acute, CholedocholithiasisUnited Kingdom
-
Asian Institute of Gastroenterology, IndiaCompleted
-
University of California, San FranciscoRecruiting
-
PerspectumCompletedLiver Diseases | Primary Sclerosing Cholangitis | Gallstones | Primary Biliary CirrhosisUnited Kingdom
-
Dana-Farber Cancer InstituteRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreatic Neoplasm | PDAC | PDAC - Pancreatic Ductal AdenocarcinomaUnited States
-
Stanford UniversityTerminatedLaryngeal Neoplasms | Head and Neck Cancers | Larynx CancerUnited States